Protagenic Therapeutics, Inc. – NASDAQ:PTIXW

Add to watchlist

$0.05

+0.04

+773.68%

Market open

Closed in about 3 hours

-25.93%

month

-25.93%

quarter

-60.00%

year

Market Cap	4.36M
Enterprise value	280.59K

P/E	-0.02
EV/Sales	N/A
EV/EBITDA	-0.05
Price/Sales	N/A
Price/Book	0.02
PEG ratio	N/A
EPS	-1.37

Revenue	N/A
EBITDA	-5.31M
Income	-6.00M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Protagenic Therapeutics, Inc. (NASDAQ:PTIXW): Profit margin
Jun 2023	0	-1.20M
Sep 2023	0	-1.39M
Dec 2023	3.2K	-1.67M	-52380.75%
Mar 2024	0	-1.72M

Protagenic Therapeutics, Inc. (NASDAQ:PTIXW): Debt to assets
Jun 2023	6919121	1.50M	21.76%
Sep 2023	5432642	1.28M	23.56%
Dec 2023	4323369	655.25K	15.16%
Mar 2024	2578558	446.09K	17.3%

Protagenic Therapeutics, Inc. (NASDAQ:PTIXW): Cash Flow
Jun 2023	-1.53M	1.61M	0
Sep 2023	-655.76K	590.72K	-10
Dec 2023	-1.14M	2.27M	10
Mar 2024	-1.65M	1.20M	0

Protagenic Therapeutics alternative data

Protagenic Therapeutics
Employees

Protagenic Therapeutics, Inc. (NASDAQ:PTIXW): Employee count
Mar 2024	2
Apr 2024	2
May 2024	1
Jun 2024	1
Jul 2024	1

Protagenic Therapeutics
Hedge Funds Holdings Q1 2023

0.01% -0.04%

of PTIXW is owned by hedge funds

1 -1

hedge funds hold PTIXW stock

25K -176.16K

shares is hold by hedge funds

PTIXW hedge funds holdings changes

Protagenic Therapeutics
Insider Trading

Protagenic Therapeutics, Inc. (NASDAQ:PTIXW): Insider trades (number of shares)
Period	Buy	Sel
Jun 2021	17000	0
May 2022	31000	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	18 May 2022	ARROW ALEXANDER K. officer: Chief Financial Officer officer: Chief Financial Officer	PTIX Common Stock	8,000	$0.72	$5,760
Purchase	17 May 2022	ARROW ALEXANDER K. officer: Chief Financial Officer officer: Chief Financial Officer	PTIX Common Stock	23,000	$0.71	$16,330
Purchase	3 Jun 2021	ARROW ALEXANDER K. officer: Chief Financial Officer officer: Chief Financial Officer	PTIXW Common Stock 5-year warrants strike price $4.98	16,900	$4.98	$84,162
Purchase	3 Jun 2021	ARROW ALEXANDER K. officer: Chief Financial Officer officer: Chief Financial Officer	PTIXW Common Stock 5-year warrants strike price $4.98	100	$4.98	$498
Purchase	27 May 2021	ARROW ALEXANDER K. officer: Chief Financial Officer officer: Chief Financial Officer	PTIXW Common Stock 5-year warrants strike price $4.98	3,000	$4.98	$14,940
Purchase	18 May 2021	ARROW ALEXANDER K. officer: Chief Financial Officer officer: Chief Financial Officer	PTIXW Common Stock 5-year warrants strike price $4.98	18,000	$4.98	$89,640
Purchase	18 May 2021	ARROW ALEXANDER K. officer: Chief Financial Officer officer: Chief Financial Officer	PTIXW Common Stock 5-year warrants strike price $4.98	12,000	$4.98	$59,760
Option	3 May 2021	BARRAGE KHALIL director director	PTIX Common stock Options	120,000	$1.75	$210,000
Option	3 May 2021	BARRAGE KHALIL director director	PTIX Common stock Options	45,000	$1.75	$78,750
Option	3 May 2021	BARRAGE KHALIL director director	PTIX Common stock Options	150,000	$1.25	$187,500

PTIXW insider trading transactions

Frequently Asked Questions (FAQ)

What's the price of Protagenic Therapeutics stock today?

One share of Protagenic Therapeutics stock can currently be purchased for approximately $0.05.
When is Protagenic Therapeutics's next earnings date?

Unfortunately, Protagenic Therapeutics's (PTIXW) next earnings date is currently unknown.
Does Protagenic Therapeutics pay dividends?

No, Protagenic Therapeutics does not pay dividends.
How much money does Protagenic Therapeutics make?

Protagenic Therapeutics has a market capitalization of 4.36M.
What is Protagenic Therapeutics's stock symbol?

Protagenic Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "PTIXW".
What is Protagenic Therapeutics's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Protagenic Therapeutics?

Shares of Protagenic Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Protagenic Therapeutics have?

As Jul 2024, Protagenic Therapeutics employs 1 workers, which is 50% less then previous quarter.
When Protagenic Therapeutics went public?

Protagenic Therapeutics, Inc. is publicly traded company for more then 4 years since IPO on 27 Apr 2021.
What is Protagenic Therapeutics's official website?

The official website for Protagenic Therapeutics is protagenic.com.
Where are Protagenic Therapeutics's headquarters?

Protagenic Therapeutics is headquartered at 149 Fifth Avenue, New York, NY.
How can i contact Protagenic Therapeutics?

Protagenic Therapeutics's mailing address is 149 Fifth Avenue, New York, NY and company can be reached via phone at +212 9948200.

Protagenic Therapeutics, Inc.

protagenic.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.

+212 9948200

149 Fifth Avenue
New York, NY 10010

CIK: 0001022899
ISIN: US74365N1110
CUSIP: 74365N111